Metformin ameliorates insulitis in STZ-induced diabetic mice

BACKGROUND & AIMS: Metformin is currently the most widely used first-line hypoglycemic agent for diabetes mellitus. Besides glucose-lowering action, there is increasingly interest in the potential anti-inflammatory action of this drug. In the present study, we investigated the actions of metform...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xue, Tao, Yu-Long, Deng, Ya-Ping, Yu, Jia-Wen, Cai, Jian, Ren, Guo-Fei, Sun, Yuan-Nan, Jiang, Guo-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2017
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399881/
https://www.ncbi.nlm.nih.gov/pubmed/28439456
http://dx.doi.org/10.7717/peerj.3155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399881/
https://www.ncbi.nlm.nih.gov/pubmed/28439456
http://dx.doi.org/10.7717/peerj.3155

Ejemplares similares